SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-23-000153
Filing Date
2023-08-14
Accepted
2023-08-14 16:07:02
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1692043604.html 4  
1 FORM 4 wk-form4_1692043604.xml 4 3904
  Complete submission text file 0001824293-23-000153.txt   5424
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Rongen Roelof (Reporting) CIK: 0001698966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 231169962

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations